Department of General, Visceral and Thoracic Surgery, Paracelsus Medical University/ Salzburger Landeskliniken (SALK), Salzburg, Austria.
Department of General and Thoracic Surgery, Academic Teaching Hospital, Feldkirch, Austria.
Langenbecks Arch Surg. 2023 Aug 8;408(1):299. doi: 10.1007/s00423-023-03037-6.
Robotic-assisted surgery is an alternative technique for patients undergoing minimal invasive cholecystectomy (CHE). The aim of this study is to compare the outcomes and costs of laparoscopic versus robotic CHE, previously described as the major disadvantage of the robotic system, in a single Austrian tertiary center.
A retrospective single-center analysis was carried out of all patients who underwent an elective minimally invasive cholecystectomy between January 2010 and August 2020 at our tertiary referral institution. Patients were divided into two groups: robotic-assisted CHE (RC) and laparoscopic CHE (LC) and compared according to demographic data, short-term postoperative outcomes and costs.
In the study period, 2088 elective minimal invasive cholecystectomies were performed. Of these, 220 patients met the inclusion criteria and were analyzed. One hundred ten (50%) patients underwent LC, and 110 patients RC. There was no significant difference in the mean operation time between both groups (RC: 60.2 min vs LC: 62.0 min; p = 0.58). Postoperative length of stay was the same in both groups (RC: 2.65 days vs LC: 2.65 days, p = 1). Overall hospital costs were slightly higher in the robotic group with a total of €2088 for RC versus €1726 for LC.
Robotic-assisted cholecystectomy is a safe and feasible alternative to laparoscopic cholecystectomy. Since there are no significant clinical and cost differences between the two procedures, RC is a justified operation for training the whole operation team in handling the system as a first step procedure. Prospective randomized trials are necessary to confirm these conclusions.
机器人辅助手术是微创胆囊切除术(CHE)患者的一种替代技术。本研究的目的是在奥地利的一家三级中心,比较腹腔镜与机器人 CHE 的结果和成本,这是机器人系统的主要缺点。
对 2010 年 1 月至 2020 年 8 月在我们的三级转诊机构接受择期微创胆囊切除术的所有患者进行了回顾性单中心分析。患者分为两组:机器人辅助 CHE(RC)和腹腔镜 CHE(LC),并根据人口统计学数据、短期术后结果和成本进行比较。
在研究期间,进行了 2088 例择期微创胆囊切除术。其中,220 例符合纳入标准并进行了分析。110 例(50%)患者行 LC,110 例 RC。两组的平均手术时间无显著差异(RC:60.2 分钟比 LC:62.0 分钟;p=0.58)。两组术后住院时间相同(RC:2.65 天比 LC:2.65 天,p=1)。机器人组的总住院费用略高,RC 组为 2088 欧元,LC 组为 1726 欧元。
机器人辅助胆囊切除术是腹腔镜胆囊切除术的一种安全可行的替代方法。由于两种手术在临床和成本方面没有显著差异,因此 RC 是培训整个手术团队操作该系统的一种合理手术,可以作为第一步手术。需要前瞻性随机试验来证实这些结论。